References
- Rees J. K. H., Gray R. G., Swinsky D., Hayhoe F. G. J. Principal results of the Medical Research Council's 8th acute myeloid leukemia trial. Lancet 1986; ii: 1236–1240
- Lihou M. G., Smith P. J. Adriamycin and cytosine arabinoside contribute equally to prediction of response in acute myelocytic leukemia with improved confidence level. Cancer Chemolher. Pharmacol. 1985; 14: 116–119
- Marie J. P., Zittoun R., Delmer A., Thevenin D., Suberville A. M. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. Leukemia 1987; 1: 121–126
- Preisler H. D., Azarnia N. Assessment of the drug sensitivity of non lymphocytic leukemia using the in vitro assay. Br. J. Haematoi 1984; 58: 633–640
- Minden M. D., Buick R. N., McCulloch E. A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloid leukemia. Blood 1979; 54: 186–195
- Marie J. P., Zittoun R., Thevenin D., Mathieu M., Viguie F. In vitro culture of clonogenic leukaemic cells in acute myelogenous leukaemia: growth pattern and drug sensitivity. Br. J. Haematoi. 1983; 55: 427–437
- Cheson B. D., Cassileth P. A., Head D. R., Schiffer C. A., Bennett J. M., Bloomfield C. D., Brunning R., Gale R. P., Grever M. R., Keating M. J., Sawitsky A., Stass S., Weinstein H., Woods W. G. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 1990; 8: 813–819
- Veerman A. J. P., Pieters R. Drug sensitivity assays in leukaemia and lymphoma. Br. J. Haematol 1990; 74: 381–384
- Park C. H., Wiemik P. J., Morrison F. S., Amare M., Van Sloten K., Maloney T. R. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drug. Cancer Res. 1983; 43: 2346–2349
- Gustavsson A., Olofsson T. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. Cancer Res. 1984; 44: 4648–4652
- Delmer A., Marie J. P., Thevenin D., Cadiou M., Viguie F., Zittoun R. Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. J. Clin. Oncol. 1989; 7: 738–746
- Marie J. P., Thevenin D., Zittoun R. In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia. Br. J. Cancer 1988; 58: 570–574
- Asano Y., Okamura S., Shibuya T., Morioka E., Hirota Y., Niho Y. Development of drug resistance in cultured clonogenic leukemic blast cells during the clinical course of myeloblastic leukemia. Oncology 1989; 46: 339–342
- Hiddemann W., Buchner T. Treatment strategies in acute myeloid leukemia (AML). B-Second line treatment. Blut. 1990; 60: 163–171
- Von Hoff D. D. The design and conduct of key clinical trials of predictive assays. Proceed. AACR. 1989; 30: 655, (abstract)
- Bird M. C., Bosanquet A. G., Gilby E. D. In vitro determination of tumour chemosensitivity in haematological malignancies. Hematological Oncology 1985; 3: 1–9
- Hongo T., Fujii Y., Igarashi Y. An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 1990; 65: 1263–1272
- Pieters R., Huismans D. R., Leyva A., Veerman A. J. P. Comparison of a rapid automated tetrazolium based (MTT)-assay with a dye exclusion assay for chemosensitivity testing in childhood leukemia. Br. J. Cancer 1989; 59: 217–220
- Twentyman P. R., Fox N. E., Rees J. K. H. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br. J. Haematol 1989; 71: 19–24
- Kirkpatrick D. L., Duke M., Goh T. S. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leukemia Res. 1990; 14: 459–466